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1. Introduction
Some time ago, I wrote a review entitled ‘‘Uncou-
pling of respiration and phosphorylation’’ for the
w xbook ‘‘Frontier of Cellular Bioenergetics’’ 1 . In that
 .paper I hypothesized that i the action of both artifi-
cial and natural uncouplers is mediated by some
 .proteins, ii uncoupling is of more general physio-
logical importance than heat production in brown fat.
In particular, it was postulated to be involved in the
cellular defence system preventing formation of su-
peroxide.
Recently several findings confirm the above con-
cepts. This allowed me to renovate and extend the
review, summarising recent progress in the solution
of the uncoupling problem.
2. What the term ‘‘uncoupling’’ means now for a
bioenergeticist?
Initially, the term ‘‘uncoupling’’ was introduced to
define respiration proceeding without phosphoryla-
tion. In 1939, the Russian biochemists Belitser and
Tsibakova found that addition of arsenate to a skele-
tal muscle mince allows respiration to occur without
w xATP formation 2 .
q qLater, when the role of Dm and Dm asH Na
convertible energy currencies was elucidated, the def-
inition of the uncoupling phenomenon was changed.
Now three types of cellular respiration differing in
their relation to energy coupling are distinguished.
 .1 Energy-coupled respiration. This is respira-
q qtion generating Dm or Dm which are thenH Na
utilized to perform useful work, namely, chemical
 . work e.g., ATP synthesis , osmotic work uphill
. transport of solutes , or mechanical work rotation of
.the bacterial flagellum .
 .2 Uncoupled respiration. Respiration forms
q qDm or Dm which are immediately dissipatedH Na
q  q.with no work performed due to high H Na
conductance through the membrane.
 .3 Non-coupled respiration. In this case respira-
qtion occurs in such a way that neither Dm norH
 .qDm are formed. This can be due to that i theNa
originally energy-coupled respiratory chain is modi-
fied in such a way that electrons are transported
without formation of the potentials this phenomenon
.  .is defined as ‘‘decoupling’’ , or ii respiratory en-
zymes other than those involved in the coupling
chain are employed.
Uncoupled and non-coupled respiration, differing
in mechanisms, are energy dissipating. Both of them,
in contrast to coupled respiration, are not controlled
by energy consumption in the cell and, therefore, can
be considered as two types of ‘‘free respiration’’
w x1,3 .
The above classification assumes that the absence
of phosphorylation does not always mean uncoupling.
Respiration occurring without phosphorylation can be
 .  .q qa energy coupled but Dm Dm are used toH H
 .perform work other than ATP synthesis, b uncou-
 .pled or c non-coupled.
3. The mechanism of action of artificial uncou-
plers: role of proteins
As was already mentioned above, arsenate proved
to be chronologically the first uncoupler described
w x2 . In this case, uncoupling is due to the fact that
ADP-arsenate, instead of ATP, is formed as the final
product of oxidative phosphorylation. ADP-arsenate
is unstable in water solution. It spontaneously decom-
poses to ADP and arsenate. Thus uncoupling occurs
in the very end of the energy transduction process.
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In 1948 Loomis and Lipmann described uncou-
 . w xpling activity of 2,4-p-dinitrophenol DNP 4 . In
1961 Mitchell explained this effect by assuming that
DNP increases the Hq conductance of the coupling
qmembranes and, hence, dissipates Dm which isH
w xgenerated by respiration 5 . Later, in Lehninger’s
laboratory it was found that DNP really increases the
Hq conductance of a planar bilayer phospholipid
 . w xmembrane BLM 6 . In our group, it was shown
that a large number of hydrophobic weak acids which
have delocalized negative charge in their ionized
 .  .form are i uncouplers in mitochondria and ii
Hq-conductors in BLMs. A correlation between effi-
ciencies of uncouplers in mitochondria and BLM was
observed, and the term ‘‘protonophore’’ was sug-
w xgested 7,8 . Independently, Chappell and Haarhoff
w x9 found that liposome membranes become perme-
able to Hq ions in the presence of an uncoupler.
w xMitchell 10 reported that this was also the case with
mitochondria.
Demonstration of the photonophorous activity of
uncouplers proved to be one of the most important
pieces of evidence in favour of the Mitchellian
w xchemiosmotic hypothesis of energy coupling 5,10 . It
has generally been accepted that in mitochondria, the
DNP anion is electrophoretically expelled from the
matrix to be protonated outside mitochondria and to
 .come back to the matrix in its neutral protonated
form. This form is deprotonated in the matrix, regen-
erating the DNP anion. All these events were as-
sumed to take place in the phospholipid region of the
inner mitochondrial membrane with no proteins in-
volved, since they could be reproduced in BLMs.
Some doubt of the absolute validity of the last
conclusion appeared when we showed that a very
 .small amount of carboxyatractylate CAtr specifi-
cally inhibiting the ATPrADP antiporter could cause
partial recoupling of the DNP-uncoupled mitochon-
dria. In fact, the level of the mitochondrial electric
 .potential DC generated by respiration was de-
 .  .Fig. 1. Partial reversal A or prevention B by carboxyatracty-
late of the uncoupling caused by low DNP concentration. Incuba-
 .tion mixture: 250mM sucrose, 10 mM MOPSrTris pH 7.4 ,
2 mM rotenone, 5 mM succinate, 2 mM EGTA, oligomycin 2 mg
y1.  y1.=ml , bovine serum albumin 0.2 mg=ml , 8 mM safranine
 y1.O. Additions: rat heart mitochondria 1 mg protein=ml ,
50 mM kCh, 2 mM CAtr.
creased by DNP and partially increased by subse-
w x  .quent addition of CAtr 11 Fig. 1 .
Later we found that the uncoupling effect of low
concentrations of the most potent artificial
 .protonophores SF6847, FCCP, CCCP and CCP on
heart or liver mitochondria, bacterial chromatophores
and cytochrome oxidase proteoliposomes is com-
 .  .pletely abolished by 6-ketocholestanol kCh Fig. 2 .
In BLM, kCh caused the opposite effect, potentiating
Fig. 2. Reversal of the SF6847-induced uncoupling by kCh in rat liver mitochondria. Incubation mixture: 250 mM sucrose, 10 mM
 .  y1.MOPSrTris pH 7.4 , oligomycin 2 mg=ml , 2 mM rotenone, 5 mM succinate and 1 mM EGTA. In B and C the mixture was
 y1.supplemented with bovine serum albumin 0.2 mg=ml and 8 mM safranin O. A, respiration; B and C, DC. Additions: mitochondria
 y1 .1.2 or 0.4 mg protein=ml in A or B, C, respectively ; 80 or 30 nM SF6847 in A or B, C, respectively; 75 or 80 mM kCh in A or B,C,
 y1. respectively; 75mM DNP; gramicidin 2 mg=mg protein . The figures above curves are respiration rates nmol O =min=mg2
y1.  w x.protein From Starkov et al. 14 .
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w xprotonophorous activity of uncouplers 12–14 . The
kCh recoupling was later reproduced in plant mito-
w xchondria by Vianello et al. 15 and in kidney mito-
w xchondria by Chavez et al. 16,17 . Recoupling resem-
bling that done by kCh was shown to be inherent in
male sex hormones and progesterone. However, this
effect proved to be specific to animal mitochondria
only and, in contrast to that of kCh, was abolished by
w xvery low concentration of fatty acids 18 . In all these
cases, no recoupling was possible when high concen-
w xtrations of protonophores were added 14,18 .
These data were hardly compatible with the classi-
cal scheme which explained uncoupling by the circu-
lation of both neutral and anionic uncoupler species
via the phospholipid regions of biological mem-
branes. It is more probable that this circulation is
 .assisted in some way by membrane protein s which
facilitate transmembrane diffusion of anionic uncou-
pler. However, if this is the case, the question arises
as to why similar concentrations of uncouplers are
 .effective i in mitochondria where their effect is
 .  .facilitated by protein s , and ii in BLM where no
protein is present.
This problem was solved when we took into ac-
count the following fact. A BLM occupies such a
small part of the experimental system that even a low
concentration of uncoupler is sufficient to saturate
this membrane. An equal quantity of uncoupler added
to a mitochondrial suspension is immediately ab-
sorbed by large amount of mitochondrial membranes,
giving a significantly lower uncoupler concentration
in the water phase than in the case of BLMs. Since
the uncoupler concentration in a membrane is equili-
brated with that in water, this means that the amount
of uncoupler added to mitochondria must be, in the
simplest case, much less efficient than the same
amount of uncoupler added to a BLM. To equalize
the acting concentrations of the uncoupler in experi-
ments with mitochondria and BLM, we supplemented
the BLM-separated solutions by the same amounts of
mitochondria as were used in the study on measuring
mitochondrial respiration and DC. This was found to
strongly increase the concentrations of the uncoupler
required to cause a measurable increase in the BLM
Hq conductance. Such an effect was especially large
 .with the most active and most hydrophobic uncou-
plers, such as SF6847. With this uncoupler, the addi-
tion of mitochondria to the BLM system before or
after SF6847 decreased the protonophore efficiency
of the uncoupler in the BLM by two orders of
w x  .magnitude 14 Fig. 3 .
Thus, the similarity of absolute values of efficien-
cies of different protonophores in mitochondria and
BLMs is, most probably, a result of the superposition
of two oppositely-directed effects. On one hand, a
BLM is, in fact, much less sensitive to uncouplers
due to the absence of uncoupling-facilitating proteins.
On the other hand, the uncouplerrlipid phase volume
ratio is much higher in the BLM experiments than in
the studies on mitochondria, a fact which makes the
w xBLM much more sensitive to the uncoupler 14 .
Within the framework of the above logic, it seems
 .probable that in mitochondria there are protein s
which specifically bind uncouplers. Reviewing quite
w xrecently this aspect, Starkov 19 concluded that there
are at least two classes of uncouplers differing in
their protein partners.
 .1 DNP-like uncouplers. 2-azido-4-nitrophenol
was shown by Hatefi’s group to cause photoaffinity
labelling predominantly of a 30 kDa protein. This
 .resulted in a inhibition of the State 3 respiration to
 .the level of State 4 and b made impossible the
w xactivation of respiration by DNP 20–22 . This looks
as if ATPrADP-antiporter, which is involved in both
 .i ADP import to support ATP synthesis inside
 . w xmitochondria and ii uncoupling by DNP 11 , has
been inactivated. If this were the case, respiration in
the photoinactivated mitochondria would be uncou-
 .pled by CCP-like uncouplers see below or arsenate.
On the other hand, it seems possible that inhibition of
the Hq-ATP-synthase by the DNP derivative occurs
since, besides the 30 kDa protein, a-subunit of factor
F was also found to be modified. If such an inhibi-1
tion would take place, arsenate uncoupling would be
arrested. In this case, ATPase activity in the inside-out
submitochondrial particles would be inhibited. Unfor-
tunately, the authors did not carry out such an analy-
sis.
 .2 CCP-like uncouplers. These uncouplers were
studied in Wilson’s group. It was found that 2-nitro-
 .4-azidocarbonylcyanide phenylhydrazone N CCP3
has a high-affinity binding site in rat heart mitochon-
w x w xdria 23 , rat liver and pigeon heart mitochondria 24 ,
and membranes of Paracoccus denitrificans and Te-
w xtrahymena pyriformis 25 . In contrast to the DNP
 .derivative, N CCP, when illuminated, a combines3
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Fig. 3. Effect of SF6847 on mitochondria, cytochrome oxidase proteoliposomes, chromatophores and BLM. Conditions: for mitochondrial
w  .  y1.experiments, the incubation medium 250 mM sucrose, 1 mM EDTA, 10 mM MOPS–Tris pH 7.4 , oligomycin 2 mg=ml , 2 mM
xrotenone, 5 mM succinate was supplemented with 8 mM safranin O, the concentration of the rat heart mitochondria was 0.7 mg
protein=mly1; for proteoliposome experiments, rotenone, succinate and oligomycin were omitted, whereas 5 mM ascorbate, 100 nM
monensin, 200 nM TMPD and 0.1 mM cytochrome c were included, the concentration of safranin O was 7 mM, that of proteoliposomes,
y3 y1 8=10 mg protein=ml ; in experiments with chromatophores, the incubation medium contained 250 mM sucrose, 5 mM MOPS pH
.  y1.7.4 , 2 mM ascorbate, 10 mM TMPD, 1 mM EGTA and oligomycin 8 mg=ml ; the BLM was made of asolectin solution in decane
 y1.  .  .50 mg=ml . Mito, rat heart mitochondria; COPL B , proteoliposomes with bovine cytochrome oxidase; COPL C , proteoliposomes
with cytochrome oxidase from the R. sphaeroides chromatophores; Chro, chromatophores; R,BLM, electric resistance of BLM;
 .  y1.R,BLM qMito , as R,BLM but rat liver mitochondria 0.7 mg protein=ml were added to the electrolyte solutions separated by the
 w x.BLM. From Starkov et al. 14 .
 .with a 10–12 kDa polypeptide, and b causes irre-
versible uncoupling. In the same group, the uncou-
pling activity of substituted 3,5-dichlorosalycylani-
lides was shown to depend upon their steric proper-
ties, another feature indicating that a specific binding
site on some mitochondrial protein is involved in the
w x uncoupling phenomenon 26 . About possible in-
volvement of proteins in uncoupling by artificial
w x .protonophores, see also, Refs. 27–30 .
In this context, it should be mentioned that the
efficiency of uncouplers usually strongly depends
upon the type of the coupling membrane studied. For
instance, SF6847 as well as FCCP and other phenyl-
hydrazone derivatives, were, in our experiments, al-
most 100-fold more efficient in mitochondria and
cytochrome oxidase asolectin proteoliposomes than
w xin Rhodobacter sphaeroides chromatophores 14 .
w xAccording to Miyoshi and Fujita 31 , SF6847 effi-
ciency in chloroplasts resembles that found in our
study on chromatophores, being much lower than in
mitochondria.
Inhibitor analysis revealed some differences be-
tween the above mentioned two groups of uncou-
plers. In contrast to the effect of the DNP-like uncou-
plers, which was partially reversed by CAtr, the
action of low concentrations of the CCP-like uncou-
 .plers and SF6847 was i completely reversed by
 .kCh, and ii CAtr resistant. The kCh recoupling
w x effect was negligible with DNP 14 see above, Fig.
 ..1 A .
It is known that the DNP-like uncouplers cross the
membrane in the form of a complex of protonated
 y.and anionic species HA rather than as an anion2
 y. w xA 32,33 . Perhaps just this property is responsible
for different behaviour of two types of uncouplers at
w xlow concentrations 14 .
On the other hand, at high concentrations all the
uncouplers operate in the inhibitor-independent fash-
ion, so this effect can be explained in terms of the
classical Mitchellian scheme which postulates the
circulation of protonophore molecules in the phos-
pholipid bilayer. The uncoupling effect of gramicidin,
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which forms Hq-, Kq- and Naq-permeable channels
in phospholipd membranes, was found to be CAtr-
and kCh-resistant at any concentration of this uncou-
w xpler 14 . Such an observations is consistent with the
assumption that the gramicidin effect is protein-inde-
pendent.
Another difference between the usual
protonophores and gramicidin is that the latter can
uncouple both ‘‘protonic’’ and ‘‘sodium’’ coupling
membranes. ‘‘Sodium’’ coupling membranes use
q qDm , instead of Dm , as a convertible energyNa H
q  qcurrency. They contain primary Na pumps DmNa
q .generators, e.g., the Na -motive respiratory chain
qqand Dm consumers e.g., the Na -driven ATP-Na
.synthase . This is the case for some marine bacteria.
The outer membrane of the animal cell belongs to the
same category: it is energized by NaqrKq-ATPase,
q
qand Dm formed is utilized by numerous Na ,Na
 w x.solute-symporters for reviews, see Refs. 3,34,35 .
In contrast to gramicidin, which fails to discrimi-
nate between Hq and Naq, there are some synthetic
Naq-specific ionophores carrying out Naq uniport
without simultaneous transport of Hq. One example
 X Xis ETH 157 N, N -dibenzyl-N, N -diphenyl-1,2-
.phenilene diacetamide . Compounds of this kind,
which can be called ‘‘sodiophores’’, specifically un-
q w xcouple Na -coupled oxidative phosphorylation 36 .
A possible role of proteins in the effect of sodio-
phores remains obscure.
4. The mechanism of action of natural uncouplers
4.1. Fatty acids
Several substances of natural origin have already
been described which cause uncoupling when added
to mitochondria or other energy-transducing systems.
Among them, fatty acids have been studied in detail.
The uncoupling effect of non-esterified fatty acids
was discovered as early as in 1956 by Pressman and
w xLardy 37 . Later it was found that, in contrast to
DNP, FCCP or gramicidin, fatty acids affect BLM
only slightly. Some decrease in the BLM resistance
could be observed only if the initial level of this
 w x.resistance was very high see, e.g., Ref. 38 . Low
efficiency of fatty acids in BLMs was found to be
due to very low permeability of phospholipid mem-
 .branes to the ionized anionic form of the fatty acid,
although its protonated form easily penetrates through
w xthese membranes 11,38–40 . Such relationships are
hardly surprising since the ionized fatty acid carbox-
ylate possesses a localized negative charge. This
charge is highly hydrated, which prevents diffusion
of the fatty acid anion through the hydrophobic mem-
brane core. On the other hand, the negative charge in
DNP or FCCP is strongly delocalized over all the
aromatic structure of the protonophore, an effect
decreasing hydration and, hence, enhancing the mem-
brane permeability.
Since fatty acids are effective uncouplers in mito-
 .chondria, I have assumed that protein component s
of the mitochondrial membrane facilitate transloca-
tion of fatty acid anions. The proteins in question
were suggested to be the so-called uncoupling protein
 .UCP; another name, thermogenin and the
w xATPrADP antiporter 3,41 .
4.1.1. Uncoupling protein in brown fat
The uncoupling protein was discovered in mito-
chondria of brown adipose tissue. UCP can amount to
10–15% of the total protein in these mitochondria
w x42,43 . It increases the permeability of the inner
mitochondrial membrane not only to Hq, but also to
a large group of anions, including short-chain fatty
y acids, hexane sulfonate, pyruvate and Cl reviewed
w x.in Ref. 41 . As for long-chain fatty acids, their
permeability was not directly measured for technical
reasons, but it is very probable that they are pene-
trants since the permeability of the UCP-containing
membrane to carboxylate anions increases with an
w xincrease in the hydrocarbon chain length 44–46 . It
was also shown that 10y6–10y5 M long-chain non-
esterified fatty acids are absolutely required for UCP
q w xto increase the H conductance 47,42 . I suggested
that it is a fatty acid anion rather than Hq that is
w xtranslocated by UCP 3,41 .
This suggestion is now supported by several lines
of evidence from Garlid’s and Jezek’s groups.
 . y1 Fatty acids compete with Cl transported into
brown fat mitochondria or UCP proteoliposomes
w x48 . Similar competition takes place between
y w xtransports of hexane sulfonate and Cl 49 .
 .2 The screening of various fatty acids and their
derivatives showed that in the UCP proteo-
 .liposomes, the structural patterns required for i
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 . q  .the fatty acid transport, ii H transport and iii
y w xcompetition with Cl are identical 50–52 .
 .3 Isolated UCP is labelled by a palmitate deriva-
 .w3 xtive, 16- 4-azido-2-nitrophenylamino H hex-4
 .adecanoic acid N -palmitate with a low stoi-3
 .chiometry 0.75 N -palmitate per UCP dimer . The3
labelling is prevented by stearate and hexane sul-
q y w xfonate and inhibits both H and Cl transport 53 .
4.1.2. Uncoupling proteins in other tissues
A question arises of how the fatty acids uncouple
in tissues other than brown fat. Immunological study
carried out some years ago revealed no brown fat
type UCP in these tissues Z. Drahota, personal com-
.munication . However, in 1997 three groups suc-
ceeded in finding mRNAs encoding for proteins simi-
 .lar but not identical to UCP in various organs and
w xcells of human, mouse and rat. Fleury et al. 54
reported that in the human genome there is a gene
that codes a protein designated UCP2 which has 59%
amino-acid identity to the human brown fat uncou-
 .pling protein now UCP1 . Both UCP1 and UCP2
exhibit three mitochondrial carrier protein motifs and
the nucleotide binding sites. A gene similar to that of
 .human UCP2 95% identity was also found in mouse.
UCP2 maps to regions of human chromosome 11 and
mouse chromosome 7 that have been linked to hyper-
insulinaemia and obesity. In comparison with UCP1,
UCP2 was found to cause stronger in vivo lowering
of mitochondrial membrane potential when expressed
in yeast and stronger inhibition of growth of yeast.
Mitochondria isolated from yeast expressing UCP2
showed higher State 4 respiration rate and lower
stimulation by FCCP or ADP. In contrast to UCP1,
the UCP2 gene is widely expressed in adult human
tissues skeletal muscle, lung, heart, placenta, kidney,
spleen, thymus, leucocytes, macrophages, bone mar-
.row and stomach . In mice the UCP2 gene expression
was found in brown fat, white fat and at high level in
heart and kidney. Low expression level was observed
in liver and brain. The UCP2 expression was upregu-
lated in white fat in response to fat feeding.
The above finding carried out by the Fleury group
initiated a study by Boss and co-workers in Switzer-
land where two more representatives of the UCP
family were shown to be expressed specifically in the
w xbrown fat and skeletal muscle tissues 55,56 . They
were called UCP3 and UCP3 where L and S areL S
for long and short, respectively. UCP3 is of se-S
quence identical to UCP3 but containing only 275L
amino acids instead of 312 in UCP3 amino acids atL
.positions 276–312 are absent . UCP3 has 57% andL
 .73% identity to UCP1 307 amino acids and UCP2
 .309 amino acids , respectively. The identity to the
most closely related mitochondrial anion carrier a-
.ketoglutaratermalate antiporter is 32%. UCP3 con-S
tains no purine nucleotide binding site responsible for
inhibition of the fatty acid-mediated uncoupling in
UCP1.
w xBoss et al. 55 confirmed that the UCP2 mRNA
was expressed in various tissues: heart)brown fat)
white adipose tissue)skeletal muscle. As for UCP3,
its mRNA was most highly expressed in the rat
brown fat, at high level in Musculus tensor fascia
 .latae fast-twitch glycolytic muscle , M. tibialis ante-
 .rior fast-twitch oxidative-glycolytic , M. gastrocne-
 . micus mixed and less in M. soleus slow twitch
.oxidative . This suggests that UCP3 is more ex-
pressed in glycolytic than in oxidative muscles. The
UCP3 mRNA was also detected, although at a much
lower level, in rat heart and kidney. In skeletal
muscles, the amount of UCP3 mRNA was much
w xhigher than that of the UCP2 mRNA 55 . Quite
w xrecently, Fleury et al. 56a postulated existence of
UCP4 which is predominantly expressed in neural
tissues. Corresponding gene was found in the X
chromosome.
The UCP3 mRNA level was not affected by cold
w xtreatment of rats 55 . On the other hand, according to
w xBoss et al. 56 expression of the UCP2 mRNA
increased by factor 2.5 in soleus muscle and brown
fat and 4.3 in heart after 48 h exposure of rats to 68C.
The same cold treatment caused 3-fold increase in the
UCP1 mRNA in brown fat. On the other hand, Fleury
w xet al. 54 failed to observe any effect of cold on the
UCP2 mRNA in mouse exposed for 10 days to 48C.
This discrepancy may be due to differences in species
or in duration of the cold exposure. In plants, one
more uncoupling protein, UCP5, was found by Fleury
w xet al. 56a . The level of the UCP5 mRNA was show
to increase when plants were exposed to cold and
decreased when the cold exposure ceased. The effects
 .could be shown both in intact plants potato and
potato tubers.
Administration of the b -adrenoreceptor agonist3
Ro-168714 for 32 h increased in brown fat the level
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w xof the UCP2 mRNA by 2.1-fold 56 , which was
w xsimilar to that of the UCP1 mRNA 57 .
Apparently the effect of cold on UCP2 is mediated
by noradrenaline. This is suggested by the fact that
stimulation of noradrenaline turnover by cold is sev-
w xeral fold in brown fat 58,59 , 48% in soleus muscle
and less than 25% in M. tibialis anterior and M.
w xgastrocnemicus 60 . Thus there is the parallelism
between stimulation of the UCP2 mRNA expression
and of the noradrenaline turnover in various tissues
w x56 .
Such a parallelism was absent when effect of 48 h
fasting was studied. It was found that fasting in-
creases UCP2 mRNA expression in M. soleus, M.
tibialis anterior and M. gastrocnemicus by 2.2, 3.6
and 2.7-fold, respectively. This was accompanied by
64% lowering of the UCP1 mRNA level in brown
fat. No changes in the UCP2 mRNA were found in
w xbrown fat and heart 56 .
w xIndependently Gimero et al. in the USA 60a have
described UCP2 mRNA in various human and mouse
tissues, with predominant expression in white fat and
skeletal muscles. In white fat, its amounts was five-
times increased when mice suffering from obesity
 .the obrob line as well as mice of the dbrdb line
were studied.
Summarising the recent observations by Fleury et
w x w xal. 54,60a , Boss et al. 55,56 and Gimero et al.
w x56a , we may conclude that now UCP should not be
considered as a brown fat-specific protein. Besides
 .‘‘classical’’ UCP1 in brown fat, there are a UCP2
 .expressed in various tissues, and b UCP3 which is
specific for brown fat and skeletal muscles, and exists
in long and short forms. UCP2 responds to cold, like
UCP1, in a noradrenaline-mediated fashion, whereas
UCP3 does not. Even for UCP2, thermoregulatory
uncoupling is hardly the only physiological function.
w xQuite recently indications were obtained 60b that
 .UCP2 and possible other UCPs are involved in the
‘‘mild’’ uncoupling preventing fast superoxide pro-
 .duction in State 4 see below, Section 5.4.2 .
 .It remains unclear i whether UCP3 and UCP3L S
 .are competent in uncoupling; ii what concentrations
of UCP are present in mitochondria of different
 .tissues; iii whether the already described uncou-
pling activity of UCP2 is mediated by fatty acids
w  .according to K. Garlid personal communication
w xthis is the case; see, however Ref. 56a . To answer
these questions, further studies should be done. How-
ever, already it seems obvious that discoveries of the
UCP family opens new perspectives for solution of
the question of natural uncoupling.
It is hardly probable that uncoupling activity of
fatty acids in tissues other than brown fat is mediated
exclusively by UCPs. Rather, UCP2 and 3 are actu-
ated under some specific conditions State 4, cold
.stress, fat feeding, fasting whereas usually the fatty
acid uncoupling is mainly assisted by some other
mitochondrial proteins. Here mitochondrial anion car-
riers, and among them first of all the ATPrADP
antiporter, should be considered.
4.1.3. Fatty acids and the ATPrADP antiporter
w xIn our group 11,61–63 it was revealed that CAtr,
the most effective specific inhibitor of the
ATPrADP-antiporter, strongly suppresses respira-
tion, increases the DC level and decreases the Hq-
conductance in heart muscle and liver mitochondria
 .uncoupled by fatty acids Fig. 4 . Other inhibitors of
the antiporter, namely atractylate, bongkrekic acid
and pyridoxal phosphate, as well as its substrate,
ADP, also have some recoupling activity which was,
w xhowever, lower than that of CAtr 11 . On the other
hand, CAtr proved to be inefficient in the inside-out
submitochondrial particles, whereas bongkrekic acid
showed recoupling activity both in mitochondria and
w xin the particles 64 . In all cases, the antiporter in-
hibitors did not recouple when FCCP or high concen-
w xtration of DNP was used as a protonophore 11 .
These data were then confirmed by others on mito-
w xchondria 65–69 , ATPrADP-antiporter proteo-
w xliposomes 70,71 and digitonin-permeabilized Ehrlich
w xascite tumor cells 68 .
w xQuite recently Kolarov and co-worker 72 re-
ported that point mutation in the yeast ATPrADP
 .antiporter R96H not only inhibits the antiport but
also strongly lowers uncoupling efficiency of fatty
acids in mitochondria isolated from this mutant.
Residual uncoupling, like that in the wild type, was
partially inhibited by bongkrekate.
A joint study of Schonfeld’s, Jezek’s and Wo-¨
w xjtczak’s groups 68,73 demonstrated that the
ATPrADP antiporter-mediated translocation of fatty
acids in the mitochondrial membrane is required for
uncoupling by these compounds. It was found that
illumination of the N -laurate-treated permeabilized3
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Fig. 4. Correlation of the effect of palmitate, ADP and CAtr on
w qx.membrane potential Ph P and respiration of skeletal muscle4
mitochondria. Incubation mixture: 0.25 M sucrose, 5 mM MOPS,
2 mM KH PO , 0.5 mM EGTA, 4 mM glutamate, 1 mM malate,2 4
 y1. q bovine serum albumin 0.2 mg=ml , 2 mM Ph P tetra-4
. phenyl phosphonium , pH 7.2. Additions: mitochondria 1.1 mg
y1.  y1.protein=ml , oligomycin 1mg=ml , 15mM palmitate,
 .0.2 mM ADP, 1mM CAtr, 40 mM dinitrophenol DNP . Temper-
ature 228C. The figures above curves are respiration rates nmol
y1 y1.  w x.O =min =mg protein . From Andreyev et al. 11 .2
ascite cells strongly suppresses the uncoupling activ-
ity of myristate. The control experiments showed that
in the dark, N -laurate uncouples, as does laurate, the3
heart muscle mitochondria in a CAtr-sensitive fash-
ion. N -palmitate was found to label around 10 mito-3
chondrial proteins. High labelling was found for a
30 kDa protein which was identified, with a specific
antibody, as the ATPrADP-antiporter. N -laurate was3
shown to cause photoinactivation of the main func-
tion of the antiporter, i.e. the ATPrADP exchange.
The above data are hardly consistent with the idea
that fatty acids operate in a ‘‘stationary’’ fashion,
either by changing the protein conformation or, when
anchored within the protein hydrophobic core, by
q w xfacilitating H trafficking 74 .
Comparing the ATPrADP-antiporter and UCP1,
one may conclude that these two proteins are evolu-
tionary closely related. They have similar sequence,
domain composition and molecular mass. Both of
them are formed without a stage of a larger precursor,
a very unusual situation for mitochondrial inner
w xmembrane proteins encoded by nuclear genes 3,41 .
Both UCP1 and the ATPrADP antiporter can com-
bine with fatty acids and purine nucleotides. The
main difference is that UPC1 can bind nucleotides
but cannot transport them through the membrane. The
binding results in the immersion of the nucleotide
into the protein. However, the final event, namely the
release of the nucleotide on the opposite membrane
side, does not occur. The nucleotide binding inhibits
the fatty acid-induced uncoupling by UCP1 as it does
by the antiporter. Generally, the ATPrADP-anti-
porter looks like a bifunctional protein carrying out
 .  .i translocation of the nucleotide anions and ii
uncoupling by translocation of the fatty acid anions.
As for UCP1, it is specialized in only one function,
namely in the fatty acid anion translocation, i.e.
uncoupling.
4.1.4. Fatty acids and other mitochondrial anion
carriers
The glutamateraspartate antiporter, the dicarbox-
ylate carrier and the phosphate carrier, three other
mitochondrial anion porters belonging to the same
family as the ATPrADP-antiporter and UCP, also
seem to be involved in the uncoupling by fatty acids.
w xSchonfeld 65 reported that the degree of CAtr-in-¨
duced recoupling of the fatty acid-uncoupled mito-
chondria is the highest in the heart muscle, the lowest
in the liver, with the kidney occupying the middle
position. This corresponds to the relative concentra-
tions of the ATPrADP antiporter in the mitochondria
of the above tissues. On the other hand, in our group
it was shown that glutamate, aspartate and diethyl
pyrocarbonate an inhibitor of the glutamateraspar-
.tate antiporter cause additional recoupling in the
liver mitochondria uncoupled by palmitate and par-
tially recoupled by a saturating concentration of CAtr
w x75–77 .
w xQuite recently, Samartsev et al. in our group 77
have found the pH-dependent reciprocal changes in
contributions of the ATPrADP antiporter and aspar-
taterglutamate antiporter to the fatty acid uncoupling
 .in rat liver mitochondria. It was found Fig. 5 that
the recoupling effect of CAtr on the fatty acid-uncou-
pled mitochondria increases and that of glutamate or
.aspartate decreases with increase in pH within the
range 7.0–7.8. The recoupling caused by combined
( )V.P. Skulache˝rBiochimica et Biophysica Acta 1363 1998 100–124110
Fig. 5. Recoupling effect of CAtr, glutamate and their combina-
tion at different pH values. Incubation mixture: 250mM sucrose,
5 mM potassium succinate, 2 mM rotenone, 3 mM MgCl , 0.5 mM2
EGTA, 5 mM MOPS–KOH, rat liver mitochondria 1 mg protein
y1.  y1.=ml , oligomycin 2 mg=ml . Additions: 1mM CAtr and
 .  w x.2 mM glutamate Glu . From Samartsev et al. 77 .
 .action of CAtr and glutamate aspartate was constant
at these pH values, being as high as 80%. The
residual 20% might be due to involvement of dicar-
boxylate andror phosphate carriers. According to
w xWieskowski and Wojtczak 78 , malonate caused
small but reproducible recoupling in liver mitochon-
dria uncoupled by myristate. On the other hand,
myristate inhibited transport of malonate to mito-
chondria. The authors concluded that dicarboxylate
carrier is involved to the fatty acid uncoupling be-
s id e s th e A T P r A D P a n tip o rte r a n d
aspartaterglutamate carrier. As for the phosphate
w xcarrier, Strabergerova and Jezek 90 reported that
micromolar concentrations of N -laurate and N -3 3
palmitate induce photoinhibition of the phosphate
transport in mitochondria and combine with the phos-
phate carrier.
4.1.5. Mechanism of the fatty acid circuit
Most probably, all the mitochondrial carriers are
 .composed of i surface-located, very specific, sub-
strate binding sites responsible for the recognition of
hydrophilic anions, namely nucleotides, amino acids,
 .dicarboxylates or phosphate, and ii non-specific
anion binding sites immersed to the hydrophobic core
of the protein, which are responsible for the translo-
cation of the recognized anions through the mem-
brane barrier. The hydrophilic substrate cannot reach
 .the type ii binding sites without assistance of the
 .type i binding sites. As for hydrophobic fatty acid
 .anions, they apparently do not need the type i
w xbinding sites 13,41 .
A tentative mechanism of the action of artificial
and natural anionic protonophores is shown on Fig. 6.
 ny.It is assumed that a natural anionic substrate A
combines with a cationic ligand of the anion carrier
 q.C close to the inner surface of the inner mitochon-
  . . qdrial membrane Fig. 6 A , step 1 . Role of C
could be performed by the lysine and arginine residues
 w xsee above, Kolarov’s data 72 on the R96H
.ATPrADP antiporter mutant . The electroneutral
complex Any flnCq is translocated to the opposite
 .  . nyouter membrane side step 2 . Here A is proto-
nated, and H A releases to the outer medium with itsn
ny subsequent spontaneous deprotonation to A steps
. q3–4 . Then nC electrophoretically return to the
 .inner membrane surface step 5 .
If an anion belongs to such a hydrophobic com-
pound as a fatty acid, its circulation is restricted to
the intramembrane space. In contrast to hydrophilic
ny   ..A , protonated fatty acid FAH in Fig. 6 B can
easily traverse the membrane, and this additional
stage results in Hq translocation from the medium to
the intramitochondrial space.
An important feature of this scheme is that the
anion carrier catalyzes not only the translocation of
an anionic compound, but also its protonation, which
is required for decomposition of the Any flnCq
  .  . .complex Fig. 6 A and B , step 3 . This may ex-
plain why such a strong acid as dodecyl sulfate
uncouples oxidative phosphorylation and increases
the Hqypermeability of mitochondria in a CAtr-sen-
w xsitive fashion 63 . Apparently the pK of dodecyla
sulfate bound to the ATPrADP carrier is much higher
than that of dodecyl sulfate in the water solution. For
fatty acids, it was shown that their binding to the
liposomal membrane results in a strong alkaline shift
w xof pK which becomes as high as 8.0 79 . This isa
not the case for dodecyl sulfate Yu. Antonenko,
.unpublished . Thus, to be protonated at neutral pH,
dodecyl sulfate seems to require something more than
being located in the water-membrane interface. Ac-
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 .cording to Fig. 6 B , this process is catalysed by the
 .anion carrier step 3 .
Within the framework of the above concept, UCP
represents the anion carrier which deals with
monoanions only, detachment of which presumably
does not require protonation of the anion-enzyme
complex. It still binds nucleotides, transports to the
membrane core but cannot release them on the oppo-
site membrane side since the protonation mechanism
is lost. On the other hand, it catalyzes the fatty acid
circuit being involved in the fatty acid anion translo-
cation. As for the anion protonation, it occurs sponta-
 .neously on the membrane surface Fig. 6C . Such an
assumption explains why UCP carries out the Hq
transport in the presence of fatty acid but does not
show protonophorous effect with strong monoanionic
acids like dodecyl sulfate and other alkyl sulphates.
These substances are transported by UCP without any
increase in the membrane proton conductance
w x44,46,41 . Dicarboxylates and other di- and polyan-
Fig. 6. A hypothetic mechanism of translocation of hydrophilic
anions and protonophores in mitochondria. It is assumed Fig.
 .. n- 6 A that efflux of the hydrophilic anion A or, e.g.,
4y 3y . nyATP rADP exchange is facilitated by combining Ain out
with a cationic ligands Cq , e.g., lysine or arginine residues of
 .protein anion carrier . To reach these ligands, the anion must
 .enter a very specific gate stage 1 . Electroneutral complex of
ny q  .A and nC is translocated to the opposite outer membrane
 .side stage 2 . Here the complex is supposed to be decomposed
by protonation of Any. As a result, H A and nCq are formedn
 . nystage 3 . The released H A immediately dissociates to A andn
q  . qnH stage 4 . As for nC , they are electrophoretically trans-
 .ported from the outer to the inner membrane surface stage 5 . It
is stage 5 that is the energy consuming process responsible for
the DC-driven efflux of Any. Uncoupling by hydrophobic fatty
acid anion FA- mediated by the same anion carrier is shown in
 . - qFig. 6 B . In this case, FA can reach cationic ligand C without
assistance of the specific gate since both FA- and Cq are
 .localized in the membrane part of the system stage 1 . When
 q.  -.cationic ligands nC are saturated by fatty acid anions nFA ,
the electroneutral complex moves to the outer membrane surface
 . q -stage 2 . Here it is broken down by adding nH to nFA soout
q  . qnFAH and nC are formed stage 3 . nC comes back to the
 .inner surface in a DC-consuming fashion stage 4 whereas
nFAH diffuses in the same direction via the lipid part of the
 . q -membrane stage 5 to give nH and nFA on the matrix surfacein
 .  .of the mitochondrial membrane stage 6 . Fig. 6 C illustrates
possible mechanism of the UCP-mediated uncoupling. It differs
 .from Fig. 6 B in that protein is no more involved in protonation
of FA-. Such a simplification of the mechanism explains why
UCP still binds nucleotide anions and even translocates them to
some depth into the membrane but cannot carry out transmem-
brane nucleotide transport. Apparently, protonation is a step
which is absolutely necessary to disrupt complex of polyanion
 . qe.g., nucleotide with nC whereas dissociation of complex
formed by fatty acid monoanion and Cq occurs much easier and
does not require special protonation mechanism. This may also
be accounted for the fact that dodecyl sulfate causes Hq trans-
port through the ATPrADP antiporter but not through UCP.
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ions are not transported by UCP. On the contrary, the
ATPrADP-antiporter was shown by our group to
mediate uncoupling by dicarboxylic fatty acids in a
w xCAtr-sensitive fashion 80 .
The schemes in Fig. 6 do not explain the mecha-
nism of action of cationic uncouplers. There are
several publications on the apparent uncoupling ef-
fect of hydrophobic weak bases which, being proto-
nated, acquire a positive charge see, e.g., Refs.
w x.81–83 . All these substances are active at higher
concentrations than SF6847, FCCP or fatty acids.
The possible involvement of carriers in their action
has not yet been studied.
4.1.6. A fatty acid effect on energy coupling at high
qDmH
w xIn 1988, Azzi and coworkers 84 discovered the
respiratory control decrease by palmitate in cy-
tochrome oxidase proteoliposomes. This effect, re-
w xcently confirmed by Sharpe et al. 85 , clearly differs
from the above described uncoupling by fatty acids.
 .i It did not require mitochondrial anion carriers.
 .ii Oleate failed to substitute for palmitate.
 . iii Uncoupling occurred at lower submicro-
.molar concentrations of palmitate than those affect-
ing UCP or the ATPrADP-antiporter.
 . qiv Apparently uncoupling required a Dm valueH
higher than some threshold since respiratory control
ratio lowered to 4 could not be decreased more at
higher palmitate concentration.
qAssumption on the threshold Dm value seems toH
w xbe confirmed in the Kadenbach group 86 . The
possible role of such a ‘‘mild’’ uncoupling will be
discussed in Section 5.4.
4.1.7. Fatty acids arrest recoupling effect of male sex
hormones
One more effect of very small fatty acid concentra-
tions was recently described in our group by Starkov
w xet al. 18 . It was shown that male sex hormones
 .testosterone and dihydrotestosterone as well as pro-
gesterone can partially recouple liver mitochondria
uncoupled by low concentrations of SF6847, FCCP
or CCCP. Recoupling required serum albumin to be
added. Addition of a small amount of palmitate 6 mM
.in the presence of 3 mM serum albumin which per se
was insufficient for uncoupling proved to completely
abolish the steroid hormone recoupling.
Fig. 7. Possible scheme for cross-talk of the uncoupling nor-
.  .adrenaline and thyroxine and recoupling male sex hormones
 w x.systems. From Starkov et al. 18 .
Interestingly, thyroid hormones introduced in vivo
or in vitro potentiated uncoupling by low concentra-
tions of SF6847. The uncoupling proved to be sensi-
tive to male sex hormones. Again recoupling was
abolished by fatty acids. It was also shown that effect
of the male sex hormones has pronounced seasonal
dependence which reversibly correlates with the level
w xof noradrenaline in the rat liver 18 .
Noradrenaline is known to be a mediator of the
w xfatty acid release during cold adaptation 3 . There-
fore, the following scheme was postulated to explain
cross-talk of thyroid and steroid hormones and nor-
adrenaline at level of the mitochondrial energy cou-
 .pling Fig. 7 .
4.2. Natural uncouplers other than fatty acids
The scheme in Fig. 7 postulates an uncoupling
mechanism other than that mediated by fatty acids. In
contrast to the fatty acid uncoupling, it is inhibited by
male sex hormones and is activated by thyroid hor-
mones. Details of this alternative uncoupling system
remain obscure. This is hardly thyroxine or its deriva-
tives per se. Thyroxine can in vitro uncouple but at
very high concentrations which are clearly non-
w x  w x.physiological 89 for review, see Ref. 87 . Lower
thyroxine concentrations stimulate uncoupling by a
small amount of SF6847 as was already mentioned in
Section 4.1.7. Structural similarity of SF6847 and the
hydrophobic part of the thyroxine molecule and the
absolute requirement of aromatic hydroxyl group for
 .  .uncoupling SF6847 and hormonal effect thyroxine
w xwas discussed elsewhere 88 .
The recoupling effect of the male sex hormones
and progesterone on the alternative uncoupling sys-
tem is quite specific. For example, epiandrosterone, a
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dihydrotestosterone isomer of very low hormonal
activity, and deoxycorticosterone, differing from pro-
gesterone by an additional OH-group at the 19th
carbon, as well as female sex hormones, show no
w xrecoupling effect 18 . Thus a special receptor seems
to be involved.
To some degree, recoupling by male sex hormones
 .is mimicked by 6-ketocholestanol kCh . However,
kCh as a more hydrophobic compound was shown to
operates in a fatty acid-resistant fashion. At low
SF6847, kCh completely recouples mitochondria in-
dependently of the season whereas the degree of the
male sex hormones-induced recoupling varies from
20% to 80% depending on season. The hormone
effect proved to be inherent in intact mitochondria,
being absent from the inside-out submitochondrial
particles, bacterial chromatophores and cytochrome
oxidase proteoliposomes. On the other hand, kCh was
w xeffective in all the systems listed 14,18 . Recoupling
w xdisappeared 5–20 min after kCh addition 14 . This
feature might be explained according to Chavez and
w xcoworkers 16,17 , by transient lowering of the mem-
brane fluidity by kCh. However, recoupling cannot
be due to such a trivial effect as decrease in mobility
of SF6847 in the membrane since protonophorous
activity of SF6847 in a BLM was not inhibited in
. w xfact, slightly stimulated by kCh 14 . Thus, in any
 .case protein s are somehow involved in the kCh
recoupling.
In this context, an interesting feature of the kCh
recoupling is that, under certain conditions, it can be
shown without SF6847 or any other added uncoupler.
This was the case in the cytochrome oxidase proteo-
qliposomes when the Dm generation rate was lim-H
ited by a low amount of added cytochrome c. In this
w xsystem, kCh addition caused an increase in DC 14 .
In liver mitochondria from hyperthyroid rats, kCh
was shown to increase DC in samples without SF6847
w x18 .
Thus, a search for natural uncouplers other than
fatty acids seems to be promising. According to
w xestimation by Brown and Brand 91 , fatty acids are
responsible for no more than 30% of the proton leak
in isolated animal mitochondria in State 4.
In plants compounds of the protonophore activity
w xare described. Ravanel and his colleagues 92–94
reported the uncoupling activity of platanetin
 .3,5,7,8-tetra-hydroxy-6-dimethylallylflavone iso-
lated from buds of the plane tree, Platanus acerifolia.
The half-maximal uncoupling effect varied from 1=
10y6 to 5=10y6 M depending on the plant species.
We confirmed the uncoupling activity of platanetin
 y5 .on rat liver mitochondria C s1.1=10 M . kCh1r2
was shown to recouple the platanetin-uncoupled mi-
w xtochondria 14 . In the same study, some kCh recou-
pling was shown for zearalenone, a compound found
 y5 . w xin plants and fungi C s7=10 M 14 . In1r2
plants, this substance seems to be related to the
w xinduction of floral buds 95 . Its uncoupling activity
on plant mitochondria was described by Vianello and
w xMacri 96,97 .
It remains unclear whether the uncoupling activity
of these two compounds is involved in their physio-
logical function. The same uncertaintly is inherent in
some other cases when a substance of natural origin
uncouples in vitro at rather high concentrations.
Under some conditions, uncoupling can occur due
to the activation of an ion transport futile cycle, e.g.,
q  . qthe circulation of K catalyzed by i the K uniport
 qwhich carries out electrophoretic K influx to mito-
.  . q q chondria and ii the K rH antiporter which facil-
q q.itates the K efflux in exchange for H . These two
porters, operating separately, cannot uncouple. How-
w xever, their co-operation results in uncoupling 98,99 .
A similar situation seems to be possible for Ca2q
when the Ca2q-uniporter and Ca2qr2Hq-antiporter
w xare co-operating 100 . Formation of non-specific
pores in the inner mitochondrial membrane is one
more kind of Ca2q-dependent uncoupling. It will be
considered later in Section 5.4. In bacteria, the circu-
lation of NHq and NH was suggested as organising4 3
w xa futile cycle 101 .
4.3. Uncoupling ˝ersus decoupling and non-coupled
respiration
In fact, isolated mitochondria always consume
some oxygen even when ADP is not added or is
 .exhausted the so-called State 4 respiration . The rate
of this respiration amounts usually to 5–20% of that
 .in the presence of ADP State 3 . This value can be
decreased under some special and obviously non-
physiological conditions EGTA, sucrose instead of
2q .KCl, serum albumin, no added Mg , etc. . Under
w xsuch conditions, Toth et al. 102 who studied heart
mitochondria from 14- to 21-day-old chicks showed
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that ADP caused stimulation of respiration by two
orders of magnitude.
 .State 4 respiration is perhaps due to i ATP
 .  .utilization inside mitochondria, ii uncoupling, iii
 .decoupling, iv non-coupled enzymatic oxygen con-
 .sumption and v non-coupled non-enzymatic oxygen
consumption resulting in the formation of superoxide
 y .O . .2
 .  .  .The contribution of i , iv and v can be esti-
 .mated by inhibitor analysis since a endogenous
 .ATP formation is blocked by oligomycin and b
non-coupled O consumptions are of different sensi-2
tivity to respiratory chain inhibitors than coupled,
uncoupled or decoupled respirations for details, see
w x.Refs. 3,88 . On the other hand, it is not so easy to
discriminate between uncoupling and decoupling see
w x.Refs. 103,104 . There are serious reasons to assume
that usually the oxygen consumption by State 4 mito-
chondria is mainly due to uncoupling.
w xRolfe and Brand 105 , when studying isolated
skeletal muscle and liver cells, concluded that uncou-
pling accounts, respectively, for about 1r4 and 1r2
of the oxygen consumption under resting conditions.
The authors assumed that uncoupling contributes 15–
w x33% of oxygen consumption by a rat in vivo 106 .
5. Physiological role of uncoupling
5.1. Alternati˝e functions of cellular respiration
On the face of it, uncoupling as a futile cycle is an
imperfection of the oxidative phosphorylation mecha-
nism. However, the situation seems more compli-
cated if we take into account the alternative functions
of cellular respiration. In fact, ATP synthesis is only
one of these functions, although usually the most
important quantitatively.
In 1962, I considered four main physiological
w xfunctions of the cellular respiration 107 :
 .1 Energy conservation.
 .  .2 Energy dissipation heating .
 .3 Production of useful substances.
 .4 Decomposition of harmful substances.
It is obvious that heat production is alternative to
energy conservation. This is why we shall, first of all,
consider thermoregulation when discussing the multi-
funtionality of respiration.
5.2. Thermoregulatory uncoupling
Experiments performed by this group showed that
when pigeons, previously adapted to cold stress, were
exposed to cold for 15 min, their skeletal muscle
mitochondria proved to be uncoupled almost com-
pletely. The effect of the cold stress was much less
w xpronounced in non-adapted pigeons 107–109 . Simi-
lar phenomenon called ‘‘thermoregulatory uncou-
.pling’’ was reproduced in mice. It was also found
that an injection of the artificial uncoupler DNP
significantly prolonged the survival time for non-
w xadapted mice at their first exposure to cold 110 .
The addition of serum albumin was found to re-
couple mitochondria from the cold-exposed pigeons.
The fraction of free fatty acids, extracted from the
mitochondria of cold-treated animals and added to
the mitochondria of non-treated animals caused un-
coupling. The total concentration of free fatty acids
strongly increased in both the muscle tissue and the
isolated muscle mitochondria of short-term cold ex-
w xposed pigeons 111 .
A piece of evidence supporting the thermoregula-
tory uncoupling in intact rat diaphragm muscle was
w xobtained in this group by Zorov and Mokhova 112 .
w xLater Grav and Blix 113 showed that mitochondria
isolated from fur seals acclimated to cold under
natural conditions have a much lower respiratory
control than those acclimated to warm conditions.
Serum albumin abolished this difference.
Thermoregulatory uncoupling discovered in mus-
cles was then described in brown fat, the mammalian
tissue specialized in additional heat production under
w xcold conditions 47,114 . Again, fatty acids proved to
be natural uncouplers involved in the thermogenic
response, the uncoupling being mediated by UCP1
and UCP2. The latter may be involved in the ther-
moregulatory uncoupling also in muscles see Section
.4.1.2 .
It is unclear whether uncoupling plays some role in
the regulatory heat production in tissues other than
muscles and brown fat. No uncoupling was revealed
in the liver mitochondria of pigeons treated with cold
w xfor a short time 107 . However, cold acclimation of
rats for several weeks resulted in some decrease in
wthe PrO ratio of isolated liver mitochondria 115–
x117 . The mechanism of this effect and its possible
role in thermoregulation remained obscure. In our
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group, uncoupling was found in liver mitochondria
from ground squirrels awaking from hibernation.
Respiration of these mitochondria could be partially
w xrecoupled by CAtr and CsA 118–120 . Uncoupling
was revealed in flowers of some plants at low ambi-
 w x.ent temperature for review, see Ref. 3 .
5.3. Non-coupled respiration: anabolic and catabolic
functions
Among the above-listed functions of respiration,
 .  .the functions 3 and 4 are related to metabolism
rather than to energetics. Formally speaking, they
might be carried out by the same energy-coupled
 .respiratory chain which is involved in function 1 .
However, if it were the case, these functions would
be tightly coupled to ATP synthesis and require ADP
to be fulfilled. Such a restriction is apparently some-
times undesirable for the cell. This is why the
metabolic functions of respiration are catalyzed, as a
rule, by non-coupled respiratory enzymes. For in-
stance, some steps of formation of steroid hormones
in adrenal cortex mitochondria, which require oxy-
genation of the steroid molecule, are mediated by
special non-coupled respiratory chain including an
NADPH-oxidizing flavoprotein, the iron–sulfur pro-
tein adrenodoxin and mitochondrial cytochrome P-
450. All of them are localized in the inner mitochon-
drial membrane together with usual components of
w xthe energy-coupled respiratory chain 121 .
The decomposition of xenobiotics is known to be
catalyzed by non-coupled respiratory chains in the
endoplasmic reticulum. These chains are terminated
by microsomal cytochromes P-450 see, e.g., Ref.
w x.122 .
5.4. Possible role of uncoupling in the antioxidant
system
q5.4.1. High Dm is dangerousH
The systems discussed in Section 5.3 exemplify
situations when the contribution of the O -consuming2
process is relatively small compared to the total
respiration rate of the cell. This cannot be the case if
we consider such a respiratory function as a decrease
in the intracellular O concentration.2
Oxygen is a strong oxidant which can chemically
oxidize some intracellular compounds with the for-
mation of Oy.. The latter initiates a chain reaction2
which involves H O and results in the appearance2 2
.  .of OH redox potential, q1.35 V , an oxidant which
is even much more aggressive than O , Oy. and2 2
H O .2 2
Components of the initial and middle parts of the
respiratory chain are the main O reductants involved2
in ‘‘parasitic’’ one-electron reduction of O to Oy. .2 2
 ..Among them, semiquinone CoQH is apparently
employed especially often.
The O concentration and CoQH. lifetime increase2
under the State 3 “ State 4 transition. This is due to
the strong decrease in the respiration rate and in-
qcrease in the Dm level, respectively. According toH
w xdata of our group 135 , not less than 20% of H O2 2
formation by heart muscle mitochondria in State 4 is
due to the bc complex, the rest being produced by1
NADH-CoQ reductase.
y.
qMechanism of the O production at high Dm2 H
qin the bc complex was explained as follows. Dm1 H
inhibits the Q-cycle in such a fashion that CoQH is2
still oxidized by the Complex III FeS protein, but
CoQH. formed cannot be oxidized by cytochrome bl
which is already completely reduced. As a result,
QH. becomes long-lived and acquires time for non-
w xenzymatic O reduction 88 . One may assume that2
qsomething like this can also occur at high Dm inH
NADH-CoQ reductase.
w xKorshunov and Starkov in our laboratory 135
showed that extremely low concentrations of uncou-
plers abolish H O production in State 4 by heart2 2
muscle mitochondria. For instance, measurable de-
crease in H O formation was already observed at2 2
2=10y10 M SF6847. This concentration was almost
4 orders of magnitude lower than the concentration of
 .cytochrome oxidase in the system used Fig. 8 .
Very steep dependence of H O formation upon2 2
the DC level explains why addition of either ADP
 .qP or an uncoupler to the State 4 mitochondriai
y. w xstrongly suppresses the O . formation 131 . The2
threshold DC value in Fig. 8 proved to be higher
than the DC value at State 3 which, under conditions
used, proved to be 82% of that in State 4.
For the first time, a steep ROS productionrDC
relationship was described by Liu Shu-sen and Huang
w x132,133 who varied the DC level by adding differ-
ent concentration of malonate to succinate-oxidizing
mitochondria. Thus we lowered DC by uncoupler or
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Fig. 8. The DC dependence of the H O production by rat heart2 2
mitochondria oxidizing succinate. The DC level was varied by
adding different concentrations of SF6847 black squares, solid
.  .line or malonate white squares . Triangle, 100 mM ADP and
5 mM potassium phosphate were added. Dashed line, the State 3
DC level. Incubation mixture: 350mM sucrose, 1 mM EGTA,
 .10 mM KCl, 10 mM MOPS pH 7.3 , 6 mM succinate, 8 mM
 .safranine O, 1.6 mM scopoletin, horseradish peroxidase 12 u , rat
 y1.heart mitochondria 1 mg protein=ml pretreated with 2 mM
H O and 10 mM aminothriazole at 48C and washed. From2 2
w x.Korshunov et al. 135 .
ADP and phosphate which increased the respiration
rate whereas Liu Shu-sen and Huang did the same by
decreasing this rate. Recently we confirmed the data
 .of the Chinese bioenergeticists Fig. 8 . The very fact
that with both uncoupler and malonate similar data
were obtained indicates that the ROS formation is a
qfunction of Dm rather than of the electron trans-H
port rate in the respiratory chain.
5.4.2. Mild uncoupling
In 1994 I postulated that mitochondria possess a
special mechanism, called ‘‘mild’’ uncoupling, which
qprevents a strong increase in Dm when ADP isH
w x  w x.exhausted 123 for details, see Refs. 88,124,125 .
It was assumed that a small decrease in the State 4
DC level shifts the Oy.. production rate below a2
threshold seen in Fig. 8.
The mechanism of mild uncoupling may be related
to the phenomenon of ‘‘non-ohmic’’ resistance of the
mitochondrial membrane. It consists of a great in-
crease in the membrane Hq conductance under con-
qditions when Dm increases above a certain thresh-H
old. The threshold in question is slightly above the
w xqState 3 Dm value 126–130 .H
w xMcCord and Turrens 134 and later Liu Shu-sen
w x133 suggested that some uncoupling might be re-
lated to the circulation of superoxide in the mitochon-
w xdrial membrane. McCord and Turrens 134 studied
the ability of intramitochondrial Mn-superoxide dis-
mutase to catalyze the Oy. “ H O conversation,2 2 2
using extramitochondrially-produced Oy. . It was2
found that the consumption of external Oy. by rat2
liver mitochondria incubated without a respiratory
substrate can be 3.7-fold increased by adding gluta-
mate and malate without ADP. The effect of these
respiratory substrates was completely arrested by an
uncoupler. The authors speculated that in State 4 a
superoxide carrier is activated, which results in fast
equilibration of Oy. across the membrane. This may2
give rise to uncoupling if one assumes that Oy. is2
electrophoretically extruded from the matrix with the
help of a carrier to come back in its protonated form,
HO. . This seemed possible since the pK value of2 a
Oy. is about 4.9 i.e. not far from that of the majority2
of artificial uncouplers and fatty acids.
However, direct experiments carried out recently
in our group by Simonyan, showed that addition of
 .potassium salt of superoxide, KO 5 mM , did not2
decrease DC in mitochondria even when the succi-
nate oxidation rate was limited by malonate R.A.
. y.Simonyan, unpublished . Apparently the O trans-2
port is too slow to induce measurable uncoupling.
Palmitate-induced decrease of the respiratory con-
 .trol Section 4.1.6 may represent one of the mecha-
nisms involved in non-ohmicity and mild uncoupling
since it takes place only at very high respiratory
qcontrol values and, hence, at maximal Dm .H
w xAccording to Brand and coworkers 104,136 ,
non-ohmicity of the mitochondrial membrane is
stronger in a hyperthyroid animal than in a hypothy-
roid one. This is apparently the reason for higher Hq
conductance of mitochondria when production of thy-
roid hormones increases for reviews, see Refs.
w x.137,87,88 .
One of the effects of thyroid hormones on the Hq
permeability of mitochondria is different from their
action via the nuclear triiodothyronine receptor. It
w xdoes not require protein synthesis 138,139 . More-
over, it develops much faster than, for example,
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induction of the a-glycerophosphate dehydrogenase,
the fast effect being mediated by diiodothyronine
w xrather than by triiodothyronine or thyroxine 138 .
There are some indications that the ATPrADP-anti-
porter possesses a specific thyroid hormone binding
w xsite of very high affinity 140–143 .
In our laboratory it was found that higher micro-
.molar concentrations of thyroid hormones added to
isolated mitochondria increase the uncoupling activ-
ity of low concentrations of SF6847 and FCCP, but
they are without effect with DNP. This effect was
abolished by kCh, male sex hormones and proges-
 .terone see above, Section 4.1.7 . This finding might
be related to the well-known antagonism of thyroid
and steroid hormones as catabolics and anabolics,
respectively. One can hypothesize that the thyroid
hormone-induced mild uncoupling decreases the risk
of hyperproduction of Oy. when the total rate of2
metabolism is stimulated by these hormones
w x88,125,18 .
It seems also possible that mild uncoupling is
related to a proton leak increase in yeast mitochon-
dria when the ATPrP ratio rises the State 3 “i
. w xState 4 transition 144 .
Quite recently, Goglia, Fleury and co-authors re-
ported about many-fold increase in the heart muscle
UCP2 mRNA level after administration of triiodothy-
w xronine to hypothyroid rat 137a . This effect can
explain mechanism of thyroid hormone-induced mild
uncoupling mediated by the nuclear triiodothyronine
receptor.
In tissues other than muscles the mild uncoupling
might also be catalyzed by UCP2. Quite recently,
w xNegre–Salvayre et al. 60b reported that GDP, effec-
tive inhibitor of the fatty-acid mediated uncoupling
by UCP, increases DC and the H O production by2 2
mitochondria from brown fat as well as from spleen,
thymus and non-parenchymal liver cells expressing
UCP2. GDP was completely ineffective in parenchy-
mal hepatocytes deprived of UCP2.
UCP3 may be one more protein involved in mild
coupling. As was mentioned in Section 4.1.2, it does
not change during cold adaptation so it is hardly
takes part in the thermoregulatory uncoupling in
.contrast to UCP1 and UCP2 . On the other hand,
UCP3 is present mainly in fast-twitch muscles where
oxygen stress is especially often due to reoxygenation
after anaerobiosis caused by performance of the heavy
muscle work. Therefore, the anti-ROS defense sys-
tem in these muscles should be especially effective.
5.4.3. Reacti˝e oxygen species-induced pores in the
inner mitochondrial membrane. Mitochondrial selec-
( )tion ‘‘mitoptosis’’
If mild uncoupling, for some reason, is unable to
prevent Oy. formation, the next line of defense must2
be actuated. This might be the opening of non-specific
pores in the inner mitochondrial membrane, which
are permeable to substances of up to 1.5 kDa molecu-
lar mass. The pore opening results in the collapse of
.
qDm , the complete oxidation of CoQH and theH
maximal stimulation of oxygen consumption which is
now controlled by respiratory enzyme activities only,
qrather than by Dm or the substrate porter activitiesH
w x123,88,125 .
The pore opening is known to be induced by an
increase in the level of Oy. and other reactive oxygen2
 .species ROS . This effect is reversible: the pores
w x close when ROS decreases for reviews, see Refs.
w x.88,125,145–148 . Just as in the case of mild uncou-
pling, pore opening is somehow controlled by thyroid
w xhormones. According to Kalderon et al. 193 , liver
mitochondria isolated from hyperthyroid animals are
more susceptible to pore opening than those from
euthyroid animals. In our group, Malkevich et al.
w x194 have shown that addition of thyroxine to iso-
lated liver mitochondria made the pore opening in-
 .sensitive to cyclosporin A CsA , the substance which
is regarded as a very specific inhibitor of this process.
To be opened, the CsA-insensitive pore requires Ca2q
transport into mitochondria, like that in samples with-
out CsA.
w xIf a mitochondrion fails to decrease ROS in spite
of the pore opening, it will degrade since both import
and synthesis of proteins by mitochondria require DC
w xwhich is absent when pores are open 149–152 . In
this way, the mitochondrial population in the cell
might be purified of the ROS superproducing or-
 w x.ganelles mitochondrial selection 88,153 . This phe-
nomenon might be related to the pore-mediated pro-
grammed destruction of mitochondria, postulated by
w xZorov et al. in 1992 154 . It can be defined as
‘‘mitoptosis’’ by analogy with apoptosis which puri-
fies the cell purification of unwonted cells see Sec-
.tion 5.4.4 .
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The ROS-induced pore opening resulting in com-
plete uncoupling of respiration and phosphorylation
might be supplemented by uncoupling of oxidation
and phosphorylation in the first glycolytic energy
coupling site. According to quite recent observation
made in our institute by Schmalhauzen and Muronetz
w x154a,154b , a very small concentration of H O2 2
causes a 300-fold increase in the rate of hydrolysis of
the acylated intermediate of glyceraldehyde-3-phos-
phate dehydrogenase reaction which normally in the
.absence of H O is phosphorolyzed to form 1,3-di-2 2
phosphoglycerate, an ATP precursor. Such a hydroly-
sis can, in principle, organize a futile cycle when
glycolytic oxidoreduction proceeds at a high rate
even without ADP.
5.4.4. Reacti˝e oxygen species-induced apoptosis.
Cellular selection
Recently some indications were obtained that the
pore opening causes programmed cell death apopto-
. w xsis 155–163 . In fact, formation of pores results in
swelling of the mitochondrial matrix, disruption of
the outer mitochondrial membrane and release of
proteins sequestered in the intermembrane space.
Among them are ‘‘mitochondrial cell suicide pro-
w xteins’’, MCSP 125,153 , namely, a 50 kDa protease
 .apoptosis inducing factor, AIF and cytochrome c. It
w xwas found by Kroemer and coworkers 156,157 that
purified AIF, when added to isolated nuclei from
HeLa cells, causes typical apoptotic changes. Inde-
w xpendently, Liu Xuesong et al. 158 showed that a
similar effect could be obtained when cytochrome c,
deoxyATP and a cytosolic fraction of unknown com-
position were simultaneously added to the nuclei
 w x.from liver cells for review, see Ref. 125 .
Observations concerning the role of cytochrome c
in apoptosis were confirmed and extended in quite
w xrecent publications by Krippner et al. 161 , Yang et
w x w xal. 162 , Kluck et al. 163 and Kharbanda et al.
w x  w x.164 reviewed by Golstein 165 .
Appearing in cytosol, cytochrome c does not in-
evitably induce apoptosis. At first it is bound by the
w xBcl-x and apparently Bcl-2 proteins 164 . TheL
apoptotic cascade should be actuated only in the case
when these proteins are saturated with cytochrome c.
An intriguing possibility consists in that desorption
of cytochrome c from mitochondrial membrane stim-
ulates the well-known Oy. -oxidizing activity of this2
cytochrome converting Oy. back to O . If it appears2 2
to be insufficient to prevent further increase in the
ROS concentration, apoptosis is actuated.
The apoptosis initiated by ROS-induced mitochon-
drial pores may be used by the organism as a way to
purify the cell population of ROS-superproducing
 . w xcells cellular selection 88,125,153 .
Thus, the following chain of events may be in-
w xvolved in the anti-ROS defense system 123 :
mild uncoupling“ROS-induced strong
uncoupling mitochondrial pore opening .
“ROS-induced mitoptosis
“ROS-induced apoptosis.
5.5. Stimulation of ATP synthesis by partial uncou-
pling
The most paradoxical function of uncoupling con-
sists of stimulating the rate of phosphorylation cou-
pled to respiration. In 1962, I suggested that the
maximal rate of ATP formation and the maximal
thermodynamic efficiency of this process cannot be
achieved simultaneously. Partial uncoupling might
stimulate the rate-limiting steps of the coupled elec-
tron transfer, thus increasing the total oxidative phos-
w xphorylation flux 107 .
In 1980 Stucki presented calculations based on
thermodynamic optimizing principles which sup-
w xported the above idea 166,167 . Later some observa-
tions were published showing that partial uncoupling
occurs in liver and muscle mitochondria isolated
from animals performing strenuous muscle work
w x168,169 . In liver, it was found that free fatty acids
w xmediate this uncoupling 169 .
In liver mitochondria, variations in uncoupling
degree between fed and fasted animals were found.
These changes were mimicked by perfusion of liver
w xwith low concentrations of fatty acids 170 . How-
ever, in this particular case uncoupling may be re-
quired for metabolism rather than for energetics. As
w x wwas concluded by Soboll 171 , ‘‘advantage of un-
xcoupling would be a relief of the strong restriction of
respiration to the ATP needs of the cell.... to maintain
a favorable mitochondrial redox state of NADq dur-
ing fatty acid oxidation and to generate ketone bodies
for peripheral organs during fasting’’. The same rea-
soning may be used to explain why the Hq perme-
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ability of the mitochondrial membrane is rather high
in embryonal liver and undergoes a profound reduc-
w xtion during the first postnatal hour 172 .
On the other hand, in all such cases, the most
difficult problem is to discriminate between the
physiologically useful effect and an in vitro artifact
or in vivo pathology. This question hardly arises
when we deal with the amount of the uncoupling
protein or corresponding mRNA rather than with
functional parameters of isolated mitochondria such
as the Hq conductance, DC or the respiratory control
 .ratio. As was already mentioned Section 4.1.2 , fat
feeding gives rise to an increase in the UCP2 mRNA
w xlevel in white fat 54 and the 48 h fasting of rats
caused 2.2–3.6 fold increase in the UCP2 mRNA
level in several skeletal muscles, whereas it was
w xunaffected in brown fat and heart 56 .
6. Pathological aspects of uncoupling
Hypo- and hyperthyroidism seem to be examples
of situations when endogenous uncoupling is too
small or too large, respectively. Unfortunately both
these pathologies are complicated by some other
w xeffects of thyroid hormones 87,171,125 . On the
other hand, it is already clear that there are in vivo
factors, others than thyroid status, which also affect
the Hq conductance of mitochondrial membranes.
The first example of a pathology of this kind was
described by Ernster, Ikkos and Luft. This was the
w xso-called ‘‘Luft disease’’ 173,174 . The authors ob-
served the loss of respiratory control in mitochondria
isolated from the skeletal muscle of a female patient
who suffered from muscle weakness. Special study
revealed that the defect was not a consequence of
hyperthyroidism. Later, several cases of the same
w xdisease were identified 175,176 .
w xAccording to Cheah et al. 177 , malignant hyper-
thermia is associated with a fatty acid-mediated un-
coupling in mitochondria. Reye’s syndrome, an acute
childrens disease associated with encephalopathy and
fatty infiltration of viscera, was shown to be accom-
panied by the appearance in blood serum of a large
amount of a dicarboxylic fatty acid inducing uncou-
w xpling 178,179 .
Ethanol consumption by rats was shown to result
in a less tight attachment of factor F to the mem-1
w xbrane, which decreases the coupling 180 . In another
study, chronic ethanol consumption by baboons was
found to activate phospholipase A in mitochondria2
and decrease the amount of mitochondrial cardiolipin,
phosphatidyl choline, as well as the content and
w xactivity of the cytochrome oxidase 181 . Oxidation
of glutathione by the alcohol dehydrogenase-pro-
duced acetaldehyde may be involved in oxidative
stress accompanying alcoholic intoxication.
A striking phenomenon was quite recently de-
w xscribed in our group by Bakeeva 182 . The author,
an electron microscopist, studied biopsy from heart
muscle of patients suffering from chronic alcoholic
cardiomyopathy. It was found that in this case, some
nuclei of the muscle cells contain numerous mito-
chondria occupying the central region of these nuclei.
Perhaps, this situation is a result of adaptation of the
muscle cell to existence under conditions when mito-
chondrial energetics is partially damaged. In this
case, the presence of mitochondria inside the nucleus
might facilitate the ATP supply of nuclear energy-
consuming processes. Another explanation might be
that ‘‘drunk’’ mitochondria loose their way, when
travelling inside the cell, and occasionally came to
the nucleus. In any case, it is obvious that mitochon-
dria are very dangerous guests for the nucleus since
the nuclear genome appears to be in close contact
with these Oy. -producing organelles.2
Ischemia, especially if it is followed by reperfu-
sion, was reported to result in uncoupling in heart
 w x.mitochondria for review, see Ref. 134 . This might
be a result of a ROS-induced damage to the mito-
chondrial membrane.
Many drugs were shown to possess an uncoupling
activity which apparently was responsible for at least
some of their side-effects. For example, the anti-
coagulant phenilin, an analogue of the protonophore
dicoumarol, causes uncoupling when added to mito-
chondria at micromolar concentrations V.P. Sku-
.lachev, unpublished .
X  .N, N -bis- 4-trifluoromethylphenyl -urea, an impu-
rity in preparations of diuron, proved to be a potent
w xuncoupler 183 .
Sometimes uncoupling explains the therapeutic ef-
fect of a drug. This is clearly the case for gramicidin
D which forms Hq-, Kq- and Naq-permeable chan-
w xnels in any phospholipid bilayers 184 . So it is
equally dangerous for bacteria, mitochondria and ani-
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mal cell outer membranes. This is why gramicidin D
is applied for external treatment only.
It is known that human serum contains a system
which kills Gram-negative bacteria by means of a
channel-forming protein fragment. This fragment is
formed due to the specific cleavage of thrombin by
bacteria. The process requires a receptor in the outer
bacterial membrane and energization of the inner
w xbacterial membrane 185,186 . All these properties
 .qproteolysis, the receptor and Dm requirementsH
are inherent in some colicines, the bacterial proteins
w xproduced by certain E. coli strains 3 .
Lactococcus lactis is found to excrete nisin, a
small ion-transporting peptide that kills other bacteria
w x187 .
Uncoupling seems to be involved in the antimicro-
bial action of magainins, cationic peptides synthe-
sized by granular glands in the skin of Xenopus
w xlae˝is 188 .
A protonophoric effect is inherent in some anti-
w xmalarial drugs 189 .
Some non-genotoxic cancerogens were shown to
w xpossess pronounced uncoupling activity 190 . On the
other hand, the specific killing of some cancer cells
w xby CCCP was described 191 . These data are in line
with recent observation by Kroemer and coworkers
that adriamycin and several other anticancer drugs
w xcause uncoupling, pore opening and apoptosis 192 .
7. Conclusions
Uncoupling is dissipation of the transmembrane
electrochemical potentials of Hq or Naq produced by
 .q qrespiratory, photosynthetic and other Dm DmH Na
generators. It is a result of an increase in the Hq
 q.Na permeability of the coupling membranes. Many
synthetic and some natural compounds are
protonophorous uncouplers.
Recent observations concerning the mechanism of
uncoupling have shaken the dogma that
photonophores circulate in the phospholipid regions
of coupling membranes. Artificial DNP, FCCP,
.  .SF6847 and natural free fatty acids uncouplers
require some proteins to effectively operate. The
family of uncoupling proteins was recently found not
only in brown fat but also in other tissues. Moreover,
the ATPrADP antiporter, the glutamateraspartate
antiporter and the dicarboxylate carrier seem to be
involved in uncoupling which has been induced by
fatty acids and partially by DNP, whereas SF6847,
FCCP and CCCP operate with the assistance of some
 .other protein s which are sensitive to 6-keto-
cholestanol.
The physiological functions of uncoupling are not
restricted to thermoregulation. Apparently, some un-
coupling is favourable for the performance of the
metabolic and even the energy-conserving functions
of cellular respiration. Moreover, it is postulated to
take part in the anti-ROS defense system of the cell,
such as decrease in local O concentration, preven-2
tion of Oy. formation by mitochondria in the resting2
state, mitochondrial selection by means of the ROS-
 .linked pore formation ‘‘mitoptosis’’ , and cellular
selection by means of the ROS-linked apoptosis.
Some pathological states are clearly related to an
enormous degree of uncoupling.
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